| 000 | 01800 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517190253.0 | ||
| 264 | 0 | _c20190722 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-017-16946-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPintarelli, Giulia | |
| 245 | 0 | 0 |
_aPharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. _h[electronic resource] |
| 260 |
_bScientific reports _c12 2017 |
||
| 300 |
_a16730 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a5' Untranslated Regions |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBupropion _xadministration & dosage |
| 650 | 0 | 4 |
_aCarbon Monoxide _xanalysis |
| 650 | 0 | 4 | _aExhalation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 | _aPharmacogenomic Variants |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xgenetics |
| 650 | 0 | 4 |
_aSmoking _xgenetics |
| 650 | 0 | 4 |
_aSmoking Cessation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTobacco Use Cessation Devices |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xgenetics |
| 650 | 0 | 4 |
_aVarenicline _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGalvan, Antonella | |
| 700 | 1 | _aPozzi, Paolo | |
| 700 | 1 | _aNoci, Sara | |
| 700 | 1 | _aPasetti, Giovanna | |
| 700 | 1 | _aSala, Francesca | |
| 700 | 1 | _aPastorino, Ugo | |
| 700 | 1 | _aBoffi, Roberto | |
| 700 | 1 | _aColombo, Francesca | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 16730 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-16946-6 _zAvailable from publisher's website |
| 999 |
_c27845984 _d27845984 |
||